China Retaliates Against European Union Device Manufacturers
Imposes a ban on European medical devicesGrowing China-EU Trade Conflict
The medical device industry is now the latest battleground in a growing China-EU trade conflict – with potential ripple effects across global supply chains and health procurement markets.
The AP reports that in an escalating trade dispute, China has barred European medical device companies from participating in government procurement contracts over 45 million yuan ($6.28 million). The ban, announced Sunday by China’s Finance Ministry, took effect immediately and is seen as retaliation for European Union trade restrictions on Chinese products.
Key Details:
- The ban applies only to non-Chinese-manufactured EU products.
- EU firms that produce within China are exempt.
- It mirrors a June EU policy excluding Chinese companies from public procurement over €5 million.
Broader EU-China Trade Tensions
- On Friday, China imposed anti-dumping duties on European brandy, particularly affecting French cognac.
- China is also investigating EU pork and dairy imports following EU actions targeting Chinese electric vehicles (EVs).
- The EU claims China’s procurement process discriminates against foreign firms, citing legal and administrative barriers.
China’s Response
China’s Ministry of Commerce said it had shown goodwill and willingness to negotiate but accused the EU of ignoring diplomatic overtures and erecting new protectionist barriers.
Read more here.
Carcinoma and Lymphomas Found Near Breast Implants
Squamous Cell Carcinoma and Various Lymphomas Located in the Capsule around Breast Implants On March 8, the US Food and Drug Administration (FDA) issued a safety communication concerning reports of squamous cell carcinoma (SCC) and various types of lymphomas in the...
A Team-based Approach to an Expedited 510(k)
Getting an expedited 510(k) submission So, you have created a new medical device by following your quality system’s design controls to plan the project, define design inputs, test to verify that outputs meet inputs, and validated your production product. Now what?...
FDA Warning Letter to Olympus Medical Systems
Letter addresses several violations of FDA&C Act On March 15, 2023, the Food and Drug Administration (FDA) issued a Warning Letter to Olympus Medical Systems Corp. The letter addressed several violations of the Federal Food, Drug, and Cosmetic Act (FD&C Act)...